These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9586268)

  • 41. Oxybutynin for detrusor instability with adjuvant salivary stimulant pastilles to improve compliance: results of a multicentre, randomized controlled trial.
    Tincello DG; Adams EJ; Sutherst JR; Richmond DH
    BJU Int; 2000 Mar; 85(4):416-20. PubMed ID: 10691817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary incontinence, hyperthermia, and sudden death.
    Herbst J; Gilbert JD; Byard RW
    J Forensic Sci; 2011 Jul; 56(4):1062-3. PubMed ID: 21470226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study.
    Diokno A; Sand P; Labasky R; Sieber P; Antoci J; Leach G; Atkinson L; Albrecht D
    Int Urol Nephrol; 2002; 34(1):43-9. PubMed ID: 12549638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute-angle closure glaucoma as a side-effect of oxybutynin.
    Sung VC; Corridan PG
    Br J Urol; 1998 Apr; 81(4):634-5. PubMed ID: 9598644
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of detrusor instability with oxybutynin rectal suppositories.
    Winkler HA; Sand PK
    Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(2):100-2. PubMed ID: 9694139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 47. A case of oxybutynin dependency.
    Guloksuz S; Eren K; Gurol DT
    Gen Hosp Psychiatry; 2010; 32(4):e5-6. PubMed ID: 20633735
    [No Abstract]   [Full Text] [Related]  

  • 48. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

  • 49. New adverse effect of oxybutynin: "night terror".
    Valsecia ME; Malgor LA; Espíndola JH; Carauni DH
    Ann Pharmacother; 1998 Apr; 32(4):506. PubMed ID: 9562151
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride.
    Katz IR; Sands LP; Bilker W; DiFilippo S; Boyce A; D'Angelo K
    J Am Geriatr Soc; 1998 Jan; 46(1):8-13. PubMed ID: 9434659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Twilight Zone: Oxybutynin Overuse Exacerbating Delirium.
    Marthi S; Pomerantz MA; Mernan AJ; Berlow YA
    J Geriatr Psychiatry Neurol; 2022 Nov; 35(6):840-845. PubMed ID: 35383492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxybutynin does not affect cyclosporin blood levels.
    Springate JE
    Ther Drug Monit; 2001 Apr; 23(2):155-6. PubMed ID: 11294516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is attempting suicide an adverse effect of oxybutynin in a child with enuresis nocturna?
    Coskun S; Yüksel H; Onag A
    Pediatr Emerg Care; 2001 Oct; 17(5):398. PubMed ID: 11673723
    [No Abstract]   [Full Text] [Related]  

  • 54. Managing Urinary Incontinence in Patients with Dementia: Pharmacological Treatment Options and Considerations.
    Orme S; Morris V; Gibson W; Wagg A
    Drugs Aging; 2015 Jul; 32(7):559-67. PubMed ID: 26169438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exaggerated neurological side-effects of oral and intravesical oxybutynin in a patient with multiple sclerosis.
    Vaidyanathan S; Krishnan KR; Soni BM; Fraser MH
    Spinal Cord; 1997 Mar; 35(3):190-1. PubMed ID: 9076875
    [No Abstract]   [Full Text] [Related]  

  • 56. Central Anticholinergic Adverse Effects and Their Measurement.
    Lampela P; Paajanen T; Hartikainen S; Huupponen R
    Drugs Aging; 2015 Dec; 32(12):963-74. PubMed ID: 26518014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. S-oxybutynin.
    Drugs R D; 2002; 3(2):84-5. PubMed ID: 12001823
    [No Abstract]   [Full Text] [Related]  

  • 58. Psychotic disorder induced by oxybutynin: Presentation of two cases.
    Gulsun M; Pinar M; Sabanci U
    Clin Drug Investig; 2006; 26(10):603-6. PubMed ID: 17163294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.
    Movig KL; Egberts AC; Lenderink AW; Leufkens HG
    J Am Geriatr Soc; 2001 Feb; 49(2):234-5. PubMed ID: 11207885
    [No Abstract]   [Full Text] [Related]  

  • 60. Characteristics of medication-induced xerostomia and effect of treatment.
    Ito K; Izumi N; Funayama S; Nohno K; Katsura K; Kaneko N; Inoue M
    PLoS One; 2023; 18(1):e0280224. PubMed ID: 36634078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.